HEADER BIOSYNTHETIC PROTEIN 29-JUN-07 2QGM TITLE CRYSTAL STRUCTURE OF SUCCINOGLYCAN BIOSYNTHESIS PROTEIN AT THE TITLE 2 RESOLUTION 1.7 A. NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET TITLE 3 BCR136. COMPND MOL_ID: 1; COMPND 2 MOLECULE: SUCCINOGLYCAN BIOSYNTHESIS PROTEIN; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: BACILLUS CEREUS ATCC 14579; SOURCE 3 ORGANISM_TAXID: 226900; SOURCE 4 STRAIN: DSM 31; SOURCE 5 GENE: BC_3205; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS Q817Z0, NESG, BCR136, STRUCTURAL GENOMICS, PSI-2, PROTEIN STRUCTURE KEYWDS 2 INITIATIVE, NORTHEAST STRUCTURAL GENOMICS CONSORTIUM, BIOSYNTHETIC KEYWDS 3 PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR A.P.KUZIN,M.ABASHIDZE,S.JAYARAMAN,H.WANG,Y.FANG,M.MAGLAQUI,L.-C.MA, AUTHOR 2 R.XIAO,J.LIU,M.C.BARAN,T.B.ACTON,B.ROST,G.T.MONTELIONE,J.F.HUNT, AUTHOR 3 L.TONG,NORTHEAST STRUCTURAL GENOMICS CONSORTIUM (NESG) REVDAT 4 30-OCT-24 2QGM 1 SEQADV LINK REVDAT 3 24-JAN-18 2QGM 1 AUTHOR JRNL REVDAT 2 24-FEB-09 2QGM 1 VERSN REVDAT 1 24-JUL-07 2QGM 0 JRNL AUTH A.P.KUZIN,M.ABASHIDZE,S.JAYARAMAN,H.WANG,Y.FANG,M.MAGLAQUI, JRNL AUTH 2 L.-C.MA,R.XIAO,J.LIU,M.C.BARAN,T.B.ACTON,B.ROST, JRNL AUTH 3 G.T.MONTELIONE,J.F.HUNT,L.TONG JRNL TITL CRYSTAL STRUCTURE OF SUCCINOGLYCAN BIOSYNTHESIS PROTEIN AT JRNL TITL 2 THE RESOLUTION 1.7 A. NORTHEAST STRUCTURAL GENOMICS JRNL TITL 3 CONSORTIUM TARGET BCR136. JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.59 REMARK 3 DATA CUTOFF (SIGMA(F)) : 1.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 190562.760 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 77.8 REMARK 3 NUMBER OF REFLECTIONS : 72134 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.229 REMARK 3 FREE R VALUE : 0.255 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 3554 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.004 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.70 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.81 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 71.00 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 10380 REMARK 3 BIN R VALUE (WORKING SET) : 0.2250 REMARK 3 BIN FREE R VALUE : 0.2420 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.00 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 542 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.010 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3180 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 256 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 17.40 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 24.40 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.49000 REMARK 3 B22 (A**2) : 4.27000 REMARK 3 B33 (A**2) : -2.78000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.23 REMARK 3 ESD FROM SIGMAA (A) : 0.12 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.25 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.09 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : 1.200 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 21.40 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.790 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.38 REMARK 3 BSOL : 44.13 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : ION.PARAM REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : ION.TOP REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: THE FRIEDEL PAIRS WERE USED FOR REMARK 3 PHASING. NO ELECTRON DENSITY FOR N-TERMINAL 32 AMINO ACIDS. THE REMARK 3 REASON COULD BE THAT THE FRACTION OF THE PROTEIN WAS REMARK 3 CRYSTALLIZED WITH THOSE RESIDUES CUT, OR, MAY BE THEY ARE REMARK 3 DISORDERED. REMARK 4 REMARK 4 2QGM COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 05-JUL-07. REMARK 100 THE DEPOSITION ID IS D_1000043573. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 06-JUN-07 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.15 REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X4A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97900 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 83023 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.700 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 89.5 REMARK 200 DATA REDUNDANCY : 19.40 REMARK 200 R MERGE (I) : 0.05900 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 21.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.76 REMARK 200 COMPLETENESS FOR SHELL (%) : 94.0 REMARK 200 DATA REDUNDANCY IN SHELL : 3.90 REMARK 200 R MERGE FOR SHELL (I) : 0.47200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: SAD REMARK 200 SOFTWARE USED: SNB REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: THE STRUCTURE FACTOR FILE CONTAINS FRIEDEL PAIRS REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 41.95 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.12 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M KSCN, 0.1M MES, 18% PEG 3350, PH REMARK 280 6.15, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 32.37300 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 43.59950 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 38.48200 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 43.59950 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 32.37300 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 38.48200 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MSE A 1 REMARK 465 ASN A 2 REMARK 465 LYS A 3 REMARK 465 LYS A 4 REMARK 465 ARG A 5 REMARK 465 MSE A 6 REMARK 465 ILE A 7 REMARK 465 ALA A 8 REMARK 465 MSE A 9 REMARK 465 VAL A 10 REMARK 465 SER A 11 REMARK 465 THR A 12 REMARK 465 ALA A 13 REMARK 465 LEU A 14 REMARK 465 LEU A 15 REMARK 465 VAL A 16 REMARK 465 THR A 17 REMARK 465 GLY A 18 REMARK 465 CYS A 19 REMARK 465 ALA A 20 REMARK 465 GLU A 21 REMARK 465 VAL A 22 REMARK 465 GLY A 23 REMARK 465 ASN A 24 REMARK 465 ALA A 25 REMARK 465 GLN A 26 REMARK 465 THR A 27 REMARK 465 VAL A 28 REMARK 465 ALA A 29 REMARK 465 VAL A 30 REMARK 465 GLU A 31 REMARK 465 ASN A 32 REMARK 465 ASN A 241 REMARK 465 GLU A 242 REMARK 465 GLN A 243 REMARK 465 ALA A 244 REMARK 465 ASN A 245 REMARK 465 THR A 246 REMARK 465 GLU A 247 REMARK 465 ILE A 248 REMARK 465 ILE A 249 REMARK 465 PRO A 250 REMARK 465 SER A 251 REMARK 465 ASN A 355 REMARK 465 PRO A 356 REMARK 465 SER A 357 REMARK 465 THR A 358 REMARK 465 GLY A 359 REMARK 465 LEU A 415 REMARK 465 PRO A 416 REMARK 465 ASN A 417 REMARK 465 SER A 418 REMARK 465 SER A 419 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 VAL A 37 -121.45 -9.99 REMARK 500 GLN A 38 -76.62 -1.69 REMARK 500 LEU A 138 139.94 -29.73 REMARK 500 LEU A 139 -31.82 90.74 REMARK 500 SER A 206 -8.85 -58.84 REMARK 500 ASP A 239 64.02 63.08 REMARK 500 ASP A 274 -157.47 -95.76 REMARK 500 ASP A 333 -120.27 55.04 REMARK 500 TYR A 351 -86.22 -85.01 REMARK 500 GLU A 353 -154.37 -85.16 REMARK 500 PRO A 382 37.54 -69.54 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: BCR136 RELATED DB: TARGETDB DBREF 2QGM A 1 445 UNP Q81BF7 Q81BF7_BACCR 1 445 SEQADV 2QGM MSE A 1 UNP Q81BF7 MET 1 CLONING ARTIFACT SEQADV 2QGM MSE A 6 UNP Q81BF7 MET 6 CLONING ARTIFACT SEQADV 2QGM MSE A 9 UNP Q81BF7 MET 9 CLONING ARTIFACT SEQADV 2QGM MSE A 70 UNP Q81BF7 MET 70 CLONING ARTIFACT SEQADV 2QGM MSE A 92 UNP Q81BF7 MET 92 CLONING ARTIFACT SEQADV 2QGM MSE A 104 UNP Q81BF7 MET 104 CLONING ARTIFACT SEQADV 2QGM MSE A 111 UNP Q81BF7 MET 111 CLONING ARTIFACT SEQADV 2QGM MSE A 148 UNP Q81BF7 MET 148 CLONING ARTIFACT SEQADV 2QGM MSE A 152 UNP Q81BF7 MET 152 CLONING ARTIFACT SEQADV 2QGM MSE A 216 UNP Q81BF7 MET 216 CLONING ARTIFACT SEQADV 2QGM MSE A 269 UNP Q81BF7 MET 269 CLONING ARTIFACT SEQADV 2QGM MSE A 291 UNP Q81BF7 MET 291 CLONING ARTIFACT SEQADV 2QGM MSE A 302 UNP Q81BF7 MET 302 CLONING ARTIFACT SEQADV 2QGM MSE A 385 UNP Q81BF7 MET 385 CLONING ARTIFACT SEQRES 1 A 445 MSE ASN LYS LYS ARG MSE ILE ALA MSE VAL SER THR ALA SEQRES 2 A 445 LEU LEU VAL THR GLY CYS ALA GLU VAL GLY ASN ALA GLN SEQRES 3 A 445 THR VAL ALA VAL GLU ASN SER GLY GLN SER VAL GLN LYS SEQRES 4 A 445 ASN ILE VAL LYS SER ILE GLN SER GLN ALA ASN PRO LEU SEQRES 5 A 445 LYS THR ILE GLU PRO SER LYS PRO PHE GLU ASP LEU LYS SEQRES 6 A 445 PRO LEU LYS LYS MSE ILE GLY ASN ALA GLN TYR VAL GLY SEQRES 7 A 445 LEU GLY GLU ASN THR HIS GLY SER SER GLU ILE PHE THR SEQRES 8 A 445 MSE LYS PHE ARG LEU VAL LYS TYR LEU VAL THR GLU MSE SEQRES 9 A 445 GLY PHE THR ASN PHE ALA MSE GLU GLU ASP TRP GLY ASN SEQRES 10 A 445 GLY LEU LYS LEU ASN GLU TYR ILE GLN THR GLY LYS GLY SEQRES 11 A 445 ASN PRO ARG GLU PHE LEU LYS LEU LEU TYR PRO THR ASP SEQRES 12 A 445 GLU ILE ILE ALA MSE ILE GLU TRP MSE LYS ASP TYR ASN SEQRES 13 A 445 ALA ASP PRO SER ASN LYS LYS LYS ILE GLN PHE ILE GLY SEQRES 14 A 445 LEU ASP LEU LYS ALA LEU ASP GLN GLY SER PHE ASN LYS SEQRES 15 A 445 VAL ILE ASP TYR VAL ARG LEU HIS ARG PRO ASP LEU LEU SEQRES 16 A 445 ALA GLU VAL GLU GLU ASN TYR LYS GLU LEU SER SER PHE SEQRES 17 A 445 THR GLY SER ILE GLN GLU TYR MSE LYS LEU THR PRO LYS SEQRES 18 A 445 LEU LYS GLU LYS PHE LYS ALA ASN ALA GLU ARG VAL ALA SEQRES 19 A 445 ARG LEU LEU LYS ASP GLU ASN GLU GLN ALA ASN THR GLU SEQRES 20 A 445 ILE ILE PRO SER GLU TYR ILE TRP ALA LYS ALA THR ALA SEQRES 21 A 445 SER ALA ILE GLU LYS PHE THR THR MSE LEU LEU PRO ASN SEQRES 22 A 445 ASP TYR PRO SER ILE ILE LYS LEU HIS GLU GLN TYR LEU SEQRES 23 A 445 ALA ASP HIS ALA MSE TRP ALA GLN GLU THR PHE GLY GLY SEQRES 24 A 445 LYS THR MSE VAL TRP ALA HIS ASN ILE HIS ILE ALA LYS SEQRES 25 A 445 GLY ILE ILE ASP GLU LYS LEU TYR PRO TYR VAL ALA GLY SEQRES 26 A 445 GLN PHE LEU LYS GLU ARG LEU ASP ASN ASN TYR VAL THR SEQRES 27 A 445 ILE GLY SER THR THR THR GLU GLY ASN PHE THR LEU TYR SEQRES 28 A 445 SER GLU TYR ASN PRO SER THR GLY GLY LYS ILE THR THR SEQRES 29 A 445 ASP THR ILE PRO GLN ASP VAL LYS SER PHE ASN TYR THR SEQRES 30 A 445 LEU GLY LYS VAL PRO TYR LYS MSE PHE LEU LEU ASP ASN SEQRES 31 A 445 ARG HIS LEU LYS GLY GLN ALA GLU LYS TRP VAL LYS ALA SEQRES 32 A 445 LYS ARG PRO LEU LEU SER ILE GLY GLY GLN ILE LEU PRO SEQRES 33 A 445 ASN SER SER VAL TYR PHE ASP THR SER LEU LEU GLU GLN SEQRES 34 A 445 PHE ASP ILE ILE PHE HIS ILE ARG LYS THR SER PRO SER SEQRES 35 A 445 HIS ILE LYS MODRES 2QGM MSE A 70 MET SELENOMETHIONINE MODRES 2QGM MSE A 92 MET SELENOMETHIONINE MODRES 2QGM MSE A 104 MET SELENOMETHIONINE MODRES 2QGM MSE A 111 MET SELENOMETHIONINE MODRES 2QGM MSE A 148 MET SELENOMETHIONINE MODRES 2QGM MSE A 152 MET SELENOMETHIONINE MODRES 2QGM MSE A 216 MET SELENOMETHIONINE MODRES 2QGM MSE A 269 MET SELENOMETHIONINE MODRES 2QGM MSE A 291 MET SELENOMETHIONINE MODRES 2QGM MSE A 302 MET SELENOMETHIONINE MODRES 2QGM MSE A 385 MET SELENOMETHIONINE HET MSE A 70 8 HET MSE A 92 8 HET MSE A 104 8 HET MSE A 111 8 HET MSE A 148 8 HET MSE A 152 8 HET MSE A 216 8 HET MSE A 269 8 HET MSE A 291 8 HET MSE A 302 8 HET MSE A 385 8 HETNAM MSE SELENOMETHIONINE FORMUL 1 MSE 11(C5 H11 N O2 SE) FORMUL 2 HOH *256(H2 O) HELIX 1 1 SER A 36 ALA A 49 1 14 HELIX 2 2 PHE A 61 ASP A 63 5 3 HELIX 3 3 LEU A 64 GLY A 72 1 9 HELIX 4 4 SER A 86 GLY A 105 1 20 HELIX 5 5 TRP A 115 GLY A 128 1 14 HELIX 6 6 ASN A 131 PHE A 135 5 5 HELIX 7 7 THR A 142 ASP A 158 1 17 HELIX 8 8 ASP A 176 ARG A 191 1 16 HELIX 9 9 LEU A 194 LYS A 203 1 10 HELIX 10 10 GLU A 204 PHE A 208 5 5 HELIX 11 11 SER A 211 MSE A 216 1 6 HELIX 12 12 THR A 219 LEU A 237 1 19 HELIX 13 13 GLU A 252 LEU A 270 1 19 HELIX 14 14 TYR A 275 GLY A 298 1 24 HELIX 15 15 HIS A 306 ALA A 311 1 6 HELIX 16 16 VAL A 323 ASP A 333 1 11 HELIX 17 17 SER A 373 VAL A 381 1 9 HELIX 18 18 ARG A 391 LEU A 393 5 3 HELIX 19 19 LYS A 394 ALA A 403 1 10 HELIX 20 20 LEU A 426 PHE A 430 1 5 SHEET 1 A 8 ASN A 50 PRO A 51 0 SHEET 2 A 8 MSE A 385 ASP A 389 -1 O LEU A 387 N ASN A 50 SHEET 3 A 8 ILE A 432 THR A 439 -1 O HIS A 435 N PHE A 386 SHEET 4 A 8 TYR A 336 LEU A 350 1 N GLY A 340 O ILE A 432 SHEET 5 A 8 TYR A 76 LEU A 79 1 N GLY A 78 O VAL A 337 SHEET 6 A 8 THR A 301 TRP A 304 1 O VAL A 303 N LEU A 79 SHEET 7 A 8 ASN A 108 ASP A 114 1 N ASN A 108 O MSE A 302 SHEET 8 A 8 GLN A 166 ASP A 171 1 O GLN A 166 N PHE A 109 SHEET 1 B 5 ASN A 50 PRO A 51 0 SHEET 2 B 5 MSE A 385 ASP A 389 -1 O LEU A 387 N ASN A 50 SHEET 3 B 5 ILE A 432 THR A 439 -1 O HIS A 435 N PHE A 386 SHEET 4 B 5 TYR A 336 LEU A 350 1 N GLY A 340 O ILE A 432 SHEET 5 B 5 THR A 363 THR A 366 -1 O THR A 363 N LEU A 350 SHEET 1 C 2 LYS A 404 LEU A 408 0 SHEET 2 C 2 TYR A 421 SER A 425 -1 O THR A 424 N ARG A 405 LINK C LYS A 69 N MSE A 70 1555 1555 1.33 LINK C MSE A 70 N ILE A 71 1555 1555 1.33 LINK C THR A 91 N MSE A 92 1555 1555 1.33 LINK C MSE A 92 N LYS A 93 1555 1555 1.33 LINK C GLU A 103 N MSE A 104 1555 1555 1.33 LINK C MSE A 104 N GLY A 105 1555 1555 1.33 LINK C ALA A 110 N MSE A 111 1555 1555 1.33 LINK C MSE A 111 N GLU A 112 1555 1555 1.33 LINK C ALA A 147 N MSE A 148 1555 1555 1.33 LINK C MSE A 148 N ILE A 149 1555 1555 1.33 LINK C TRP A 151 N MSE A 152 1555 1555 1.33 LINK C MSE A 152 N LYS A 153 1555 1555 1.33 LINK C TYR A 215 N MSE A 216 1555 1555 1.33 LINK C MSE A 216 N LYS A 217 1555 1555 1.33 LINK C THR A 268 N MSE A 269 1555 1555 1.33 LINK C MSE A 269 N LEU A 270 1555 1555 1.33 LINK C ALA A 290 N MSE A 291 1555 1555 1.33 LINK C MSE A 291 N TRP A 292 1555 1555 1.33 LINK C THR A 301 N MSE A 302 1555 1555 1.33 LINK C MSE A 302 N VAL A 303 1555 1555 1.33 LINK C LYS A 384 N MSE A 385 1555 1555 1.33 LINK C MSE A 385 N PHE A 386 1555 1555 1.33 CRYST1 64.746 76.964 87.199 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015445 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012993 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011468 0.00000